CARGO Therapeutics (formerly known as Syncopation Life Sciences) is a company that develops a platform for cancer treatment. Its technology involves engineering chimeric antigen receptors (CAR) T-cells with genetic material and then transporting this therapeutic “cargo” into a patient’s body, so it can recognize and kill cancer cells.